{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:51:31Z","timestamp":1787316691120,"version":"build-2736575974"},"reference-count":156,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000765","name":"UCL","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000765","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","sfnmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Fetal and Neonatal Medicine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.siny.2021.101256","type":"journal-article","created":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T19:44:34Z","timestamp":1623527074000},"page":"101256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Therapies for neonatal encephalopathy: Targeting the latent, secondary and tertiary phases of evolving brain injury"],"prefix":"10.1016","volume":"26","author":[{"given":"Aravanan A.","family":"Chakkarapani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hany","family":"Aly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Benders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Michael","family":"Cotten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"El-Dib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Gressens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Hagberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemmen","family":"Sabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Wintermark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola J.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.siny.2021.101256_bib1","doi-asserted-by":"crossref","first-page":"F301","DOI":"10.1136\/archdischild-2017-313707","article-title":"g. Brain Injuries expert working, Neonatal brain injuries in England: population-based incidence derived from routinely recorded clinical data held in the National Neonatal Research Database","volume":"103","author":"Gale","year":"2018","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.siny.2021.101256_bib2","series-title":"O. Royal College of, gynaecologists, each baby counts: 2018 progress report","first-page":"1","year":"2018"},{"issue":"Suppl 1","key":"10.1016\/j.siny.2021.101256_bib3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/pr.2013.206","article-title":"Intrapartum-related neonatal encephalopathy incidence and impairment at regional and global levels for 2010 with trends from 1990","volume":"74","author":"Lee","year":"2013","journal-title":"Pediatr Res"},{"issue":"6","key":"10.1016\/j.siny.2021.101256_bib4","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1001\/archpediatrics.2011.1772","article-title":"Hypothermia for neonatal hypoxic ischemic encephalopathy: an updated systematic review and meta-analysis","volume":"166","author":"Tagin","year":"2012","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"12","key":"10.1016\/j.siny.2021.101256_bib5","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/apa.13146","article-title":"Less severe cerebral palsy outcomes in infants treated with therapeutic hypothermia","volume":"104","author":"Jary","year":"2015","journal-title":"Acta Paediatr"},{"issue":"1","key":"10.1016\/j.siny.2021.101256_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/archdischild-2018-316509","article-title":"School-age outcomes of children without cerebral palsy cooled for neonatal hypoxic-ischaemic encephalopathy in 2008-2010","volume":"105","author":"Lee-Kelland","year":"2020","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"10","key":"10.1016\/j.siny.2021.101256_bib7","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.4103\/1673-5374.257512","article-title":"Can we further optimize therapeutic hypothermia for hypoxic-ischemic encephalopathy?","volume":"14","author":"Davies","year":"2019","journal-title":"Neural Regen Res"},{"issue":"4","key":"10.1016\/j.siny.2021.101256_bib8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jpeds.2011.12.052","article-title":"Which neuroprotective agents are ready for bench to bedside translation in the newborn infant?","volume":"160","author":"Robertson","year":"2012","journal-title":"J Pediatr"},{"key":"10.1016\/j.siny.2021.101256_bib9","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1203\/00006450-199412000-00003","article-title":"Delayed (\"secondary\") cerebral energy failure after acute hypoxia-ischemia in the newborn piglet: continuous 48-hour studies by phosphorus magnetic resonance spectroscopy","volume":"36","author":"Lorek","year":"1994","journal-title":"Pediatr Res"},{"issue":"5","key":"10.1016\/j.siny.2021.101256_bib10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1203\/00006450-198905000-00004","article-title":"Prognosis of newborn infants with hypoxic-ischemic brain injury assessed by phosphorus magnetic resonance spectroscopy","volume":"25","author":"Azzopardi","year":"1989","journal-title":"Pediatr Res"},{"issue":"6","key":"10.1016\/j.siny.2021.101256_bib11","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1046\/j.0953-816x.2001.01474.x","article-title":"Bacterial endotoxin sensitizes the immature brain to hypoxic--ischaemic injury","volume":"13","author":"Eklind","year":"2001","journal-title":"Eur J Neurosci"},{"issue":"6","key":"10.1016\/j.siny.2021.101256_bib12","first-page":"279","article-title":"Positive and negative conditioning in the neonatal brain","volume":"1","author":"Vexler","year":"2018","journal-title":"Cond Med"},{"issue":"3","key":"10.1016\/j.siny.2021.101256_bib13","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1203\/00006450-199909000-00005","article-title":"Hypothermia is not neuroprotective when started after postischemic seizures in fetal sheep","volume":"46","author":"Gunn","year":"1999","journal-title":"Pediatr Res"},{"key":"10.1016\/j.siny.2021.101256_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.brainres.2007.03.083","article-title":"Therapeutic time window\u201d duration decreases with increasing severity of cerebral hypoxia-ischaemia under normothermia and delayed hypothermia in newborn piglets","volume":"1154","author":"Iwata","year":"2007","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.siny.2021.101256_bib15","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1203\/00006450-199909000-00005","article-title":"Cerebral hypothermia is not neuroprotective when started after postischemic seizures in fetal sheep","volume":"46","author":"Gunn","year":"1999","journal-title":"Pediatr Res"},{"issue":"16","key":"10.1016\/j.siny.2021.101256_bib16","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1001\/jama.2017.14972","article-title":"Effect of therapeutic hypothermia initiated after 6 hours of age on death or disability among newborns with hypoxic-ischemic encephalopathy: a randomized clinical trial","volume":"318","author":"Laptook","year":"2017","journal-title":"J Am Med Assoc"},{"issue":"Pt 1","key":"10.1016\/j.siny.2021.101256_bib17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1113\/jphysiol.2005.100768","article-title":"Post-hypoxic hypoperfusion is associated with suppression of cerebral metabolism and increased tissue oxygenation in near-term fetal sheep","volume":"572","author":"Jensen","year":"2006","journal-title":"J Physiol"},{"issue":"2","key":"10.1016\/j.siny.2021.101256_bib18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1474-4422(13)70261-8","article-title":"Mitochondria: hub of injury responses in the developing brain","volume":"13","author":"Hagberg","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.siny.2021.101256_bib19","article-title":"Proton magnetic resonance spectroscopy lactate\/N-acetylaspartate within 2 weeks of birth accurately predicts 2-year motor, cognitive and language outcomes in neonatal encephalopathy after therapeutic hypothermia","author":"Mitra","year":"2018","journal-title":"Archives Dis Child Fetal and Neonatal"},{"issue":"18","key":"10.1016\/j.siny.2021.101256_bib20","first-page":"30325","article-title":"Magnetic resonance spectroscopy assessment of brain injury after moderate hypothermia in neonatal encephalopathy: a prospective multicentre cohort study","volume":"S1474\u20134422","author":"Lally","year":"2018","journal-title":"Lancet Neurol pii"},{"issue":"6","key":"10.1016\/j.siny.2021.101256_bib21","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/ana.10365","article-title":"Brain alkaline intracellular pH after neonatal encephalopathy","volume":"52","author":"Robertson","year":"2002","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.siny.2021.101256_bib22","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S1474-4422(12)70058-3","article-title":"Tertiary mechanisms of brain damage: a new hope for treatment of cerebral palsy?","volume":"11","author":"Fleiss","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.siny.2021.101256_bib23","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1742-2094-11-98","article-title":"Neuroinflammation and M2 microglia: the good, the bad, and the inflamed","volume":"11","author":"Cherry","year":"2014","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.siny.2021.101256_bib24","doi-asserted-by":"crossref","DOI":"10.1177\/0271678X20963405","article-title":"Microglia\/macrophage polarization: Fantasy or evidence of functional diversity?","author":"Hu","year":"2020","journal-title":"J Cereb Blood Flow Metab."},{"issue":"8","key":"10.1016\/j.siny.2021.101256_bib25","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nn.4338","article-title":"A polarizing question: do M1 and M2 microglia exist?","volume":"19","author":"Ransohoff","year":"2016","journal-title":"Nat Neurosci"},{"issue":"32","key":"10.1016\/j.siny.2021.101256_bib26","doi-asserted-by":"crossref","first-page":"11281","DOI":"10.1523\/JNEUROSCI.1685-15.2015","article-title":"Neuronal interleukin-4 as a modulator of microglial pathways and ischemic brain damage","volume":"35","author":"Zhao","year":"2015","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.siny.2021.101256_bib27","doi-asserted-by":"crossref","first-page":"F250","DOI":"10.1136\/archdischild-2017-312744","article-title":"Perinatal risk factors for neonatal encephalopathy: an unmatched case-control study","volume":"103","author":"Tann","year":"2018","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"2","key":"10.1016\/j.siny.2021.101256_bib28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00019052-200004000-00004","article-title":"Infection, inflammation and the risk of cerebral palsy","volume":"13","author":"Nelson","year":"2000","journal-title":"Curr Opin Neurol"},{"issue":"9","key":"10.1016\/j.siny.2021.101256_bib29","doi-asserted-by":"crossref","first-page":"10184","DOI":"10.1038\/s41598-019-46488-y","article-title":"Acute LPS sensitization and continuous infusion exacerbates hypoxic brain injury in a piglet model of neonatal encephalopathy","volume":"15","author":"Martinello","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.siny.2021.101256_bib30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/1531-8249(200001)47:1<54::AID-ANA10>3.0.CO;2-Y","article-title":"Proinflammatory cytokines and interleukin-9 exacerbate excitotoxic lesions of the newborn murine neopallium","volume":"47","author":"Dommergues","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.siny.2021.101256_bib31","series-title":"Hypothermia is neuroprotective after severe hypoxic-ischaemic brain injury in neonatal rats pre-exposed to PAM3CSK4","first-page":"189","author":"Falck","year":"2018"},{"key":"10.1016\/j.siny.2021.101256_bib32","article-title":"Hypothermia is not neuroprotective after infection-sensitized neonatal hypoxic-ischemic brain injury","author":"Osredkar","year":"2013","journal-title":"Resuscitation"},{"issue":"6","key":"10.1016\/j.siny.2021.101256_bib33","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s11940-012-0200-y","article-title":"Therapeutic hypothermia for neonatal encephalopathy","volume":"14","author":"Shankaran","year":"2012","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.siny.2021.101256_bib34","doi-asserted-by":"crossref","DOI":"10.1159\/000353948","article-title":"Time is brain: starting therapeutic hypothermia within three hours after birth improves motor outcome in asphyxiated newborns","volume":"104","author":"Thoresen","year":"2013","journal-title":"Neonatology"},{"issue":"1","key":"10.1016\/j.siny.2021.101256_bib35","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1161\/STROKEAHA.114.007330","article-title":"Brain cell death is reduced with cooling by 3.5\u00b0C to 5\u00b0C but increased with cooling by 8.5\u00b0C in a piglet asphyxia model","volume":"46","author":"Alonso-Alconada","year":"2015","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.siny.2021.101256_bib36","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1177\/0271678X17707671","article-title":"How long is sufficient for optimal neuroprotection with cerebral cooling after ischemia in fetal sheep?","volume":"38","author":"Davidson","year":"2018","journal-title":"J Cerebr Blood Flow Metabol"},{"issue":"1","key":"10.1016\/j.siny.2021.101256_bib37","doi-asserted-by":"crossref","first-page":"10142","DOI":"10.1038\/s41598-019-46505-0","article-title":"Differential effects of slow rewarming after cerebral hypothermia on white matter recovery after global cerebral ischemia in near-term fetal sheep","volume":"9","author":"Draghi","year":"2019","journal-title":"Sci Rep"},{"issue":"24","key":"10.1016\/j.siny.2021.101256_bib38","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1001\/jama.2014.16058","article-title":"Effect of depth and duration of cooling on deaths in the NICU among neonates with hypoxic ischemic encephalopathy: a randomized clinical trial","volume":"312","author":"Shankaran","year":"2014","journal-title":"J Am Med Assoc"},{"issue":"1","key":"10.1016\/j.siny.2021.101256_bib39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jama.2017.7218","article-title":"Effect of depth and duration of cooling on death or disability at age 18 Months among neonates with hypoxic-ischemic encephalopathy: a randomized clinical trial","volume":"318","author":"Shankaran","year":"2017","journal-title":"J Am Med Assoc"},{"issue":"7","key":"10.1016\/j.siny.2021.101256_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/children5070099","article-title":"Current and emerging therapies in the management of hypoxic ischemic encephalopathy in neonates","volume":"5","author":"Nair","year":"2018","journal-title":"Children"},{"issue":"38","key":"10.1016\/j.siny.2021.101256_bib41","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.2174\/1381612823666170918123307","article-title":"Allopurinol: old drug, new indication in neonates?","volume":"23","author":"Annink","year":"2017","journal-title":"Curr Pharmaceut Des"},{"issue":"4","key":"10.1016\/j.siny.2021.101256_bib42","first-page":"405","article-title":"Allopurinol administered after inducing hypoxia-ischemia reduces brain injury in 7-day-old rats","volume":"33","author":"Palmer","year":"1993","journal-title":"Pediatr Res"},{"issue":"9","key":"10.1016\/j.siny.2021.101256_bib43","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1161\/01.STR.0000028343.25901.09","article-title":"Neuroprotection by selective nitric oxide synthase inhibition at 24 hours after perinatal hypoxia-ischemia","volume":"33","author":"Peeters-Scholte","year":"2002","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.siny.2021.101256_bib44","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1203\/01.PDR.0000081297.53793.C6","article-title":"Effects of allopurinol and deferoxamine on reperfusion injury of the brain in newborn piglets after neonatal hypoxia-ischemia","volume":"54","author":"Peeters-Scholte","year":"2003","journal-title":"Pediatr Res"},{"key":"10.1016\/j.siny.2021.101256_bib45","first-page":"CD006817","article-title":"Allopurinol for preventing mortality and morbidity in newborn infants with hypoxic-ischaemic encephalopathy","volume":"7","author":"Chaudhari","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.siny.2021.101256_bib46","series-title":"Long-term neuroprotective effects of allopurinol after moderate perinatal asphyxia. Follow-up of two randomised controlled trials","author":"Kaandorp","year":"2011"},{"key":"10.1016\/j.siny.2021.101256_bib47","doi-asserted-by":"crossref","first-page":"F216","DOI":"10.1136\/archdischild-2014-306769","article-title":"Maternal allopurinol administration during suspected fetal hypoxia: a novel neuroprotective intervention? A multicentre randomised placebo controlled trial","author":"Kaandorp","year":"2015","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"8","key":"10.1016\/j.siny.2021.101256_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201063","article-title":"Behavioral and neurodevelopmental outcome of children after maternal allopurinol administration during suspected fetal hypoxia: 5-year follow up of the ALLO-trial","volume":"13","author":"Klumper","year":"2018","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.siny.2021.101256_bib49","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12887-019-1566-8","volume":"19","author":"Maiwald","year":"2019","journal-title":"BMC Pediatr"},{"issue":"1","key":"10.1016\/j.siny.2021.101256_bib50","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1179\/joc.1997.9.1.23","article-title":"Requirements for intracellular accumulation and release of clarithromycin and azithromycin by human phagocytes","volume":"9","author":"Fietta","year":"1997","journal-title":"J Chemother"},{"issue":"2","key":"10.1016\/j.siny.2021.101256_bib51","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pharmthera.2014.03.003","article-title":"Azithromycin: mechanisms of action and their relevance for clinical applications","volume":"143","author":"Parnham","year":"2014","journal-title":"Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.siny.2021.101256_bib52","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41390-019-0408-6","article-title":"Repurposing azithromycin for neonatal neuroprotection","volume":"86","author":"Barks","year":"2019","journal-title":"Pediatr Res"},{"issue":"1","key":"10.1016\/j.siny.2021.101256_bib53","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.expneurol.2015.10.012","article-title":"Azithromycin protects mice against ischemic stroke injury by promoting macrophage transition towards M2 phenotype","volume":"275","author":"Amantea","year":"2016","journal-title":"Exp Neurol"},{"issue":"3","key":"10.1016\/j.siny.2021.101256_bib54","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/jac\/dkn007","article-title":"Azithromycin alters macrophage phenotype","volume":"61","author":"Murphy","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.siny.2021.101256_bib55","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3389\/fnins.2018.00241","article-title":"Paradigm shift to neuroimmunomodulation for translational neuroprotection in stroke","volume":"12","author":"Amantea","year":"2018","journal-title":"Front Neurosci"},{"key":"10.1016\/j.siny.2021.101256_bib56","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3389\/fimmu.2014.00532","article-title":"Metabolism via arginase or nitric oxide synthase: two competing arginine pathways in macrophages","volume":"5","author":"Rath","year":"2014","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.siny.2021.101256_bib57","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/01.JAA.0000511033.34198.95","article-title":"Is cardiovascular risk a concern when prescribing azithromycin?","volume":"30","author":"Sutton","year":"2017","journal-title":"JAAPA"},{"issue":"24","key":"10.1016\/j.siny.2021.101256_bib58","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1056\/NEJM199806113382401","article-title":"Prolongation of the QT interval and the sudden infant death syndrome","volume":"338","author":"Schwartz","year":"1998","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.siny.2021.101256_bib59","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1542\/peds.111.2.244","article-title":"Treatment of term infants with head cooling and mild systemic hypothermia (35.0 degrees C and 34.5 degrees C) after perinatal asphyxia","volume":"111","author":"Battin","year":"2003","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.siny.2021.101256_bib60","article-title":"Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants","volume":"2","author":"Ohlsson","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.siny.2021.101256_bib61","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/pan.13731","article-title":"A target concentration strategy to determine ibuprofen dosing in children","volume":"29","author":"Anderson","year":"2019","journal-title":"Paediatr Anaesth"},{"issue":"4","key":"10.1016\/j.siny.2021.101256_bib62","doi-asserted-by":"crossref","first-page":"e1002","DOI":"10.1542\/peds.2007-0064","article-title":"Cerebrospinal fluid distribution of ibuprofen after intravenous administration in children","volume":"120","author":"Kokki","year":"2007","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.siny.2021.101256_bib63","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0165-0173(93)90010-W","article-title":"Ascorbic acid in the brain","volume":"18","author":"Grunewald","year":"1993","journal-title":"Brain Res. Brain Res. Rev."},{"issue":"9","key":"10.1016\/j.siny.2021.101256_bib64","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1096\/fasebj.13.9.1007","article-title":"Does vitamin C act as a pro-oxidant under physiological conditions?","volume":"13","author":"Carr","year":"1999","journal-title":"Faseb J"},{"issue":"4","key":"10.1016\/j.siny.2021.101256_bib65","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3171\/jns.2003.98.4.0860","article-title":"High-dose ibuprofen for reduction of striatal infarcts during middle cerebral artery occlusion in rats","volume":"98","author":"Antezana","year":"2003","journal-title":"J Neurosurg"},{"issue":"12","key":"10.1016\/j.siny.2021.101256_bib66","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/NEN.0b013e318277d4c7","article-title":"Post-insult ibuprofen treatment attenuates damage to the serotonergic system after hypoxia-ischemia in the immature rat brain","volume":"71","author":"Wixey","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.siny.2021.101256_bib67","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.brainres.2011.06.001","article-title":"Ibuprofen inhibits neuroinflammation and attenuates white matter damage following hypoxia-ischemia in the immature rodent brain","volume":"1402","author":"Carty","year":"2011","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.siny.2021.101256_bib68","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.neuroscience.2005.01.021","article-title":"Ibuprofen protects ischemia-induced neuronal injury via up-regulating interleukin-1 receptor antagonist expression","volume":"132","author":"Park","year":"2005","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.siny.2021.101256_bib69","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.brainres.2006.04.045","article-title":"Intraventricular ascorbic acid administration decreases hypoxic-ischemic brain injury in newborn rats","volume":"1095","author":"Miura","year":"2006","journal-title":"Brain Res"},{"issue":"6","key":"10.1016\/j.siny.2021.101256_bib70","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/jp.2009.1","article-title":"Ascorbic acid combined with ibuprofen in hypoxic ischemic encephalopathy: a randomized controlled trial","volume":"29","author":"Aly","year":"2009","journal-title":"J Perinatol"},{"issue":"4","key":"10.1016\/j.siny.2021.101256_bib71","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.toxicon.2010.12.016","article-title":"The development of Byetta (exenatide) from the venom of the Gila monster as an anti-diabetic agent","volume":"59","author":"Furman","year":"2012","journal-title":"Toxicon"},{"issue":"2","key":"10.1016\/j.siny.2021.101256_bib72","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.regpep.2003.10.028","article-title":"Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes","volume":"117","author":"Nielsen","year":"2004","journal-title":"Regul Pept"},{"issue":"10","key":"10.1016\/j.siny.2021.101256_bib73","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1093\/brain\/awy220","article-title":"Neuroprotective exendin-4 enhances hypothermia therapy in a model of hypoxic-ischaemic encephalopathy","volume":"141","author":"Rocha-Ferreira","year":"2018","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.siny.2021.101256_bib74","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1046\/j.1471-4159.2003.02224.x","article-title":"Neuregulin-1-beta1 enters brain and spinal cord by receptor-mediated transport","volume":"88","author":"Kastin","year":"2004","journal-title":"J Neurochem"},{"issue":"3","key":"10.1016\/j.siny.2021.101256_bib75","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1365-201X.1996.42256000.x","article-title":"Distribution of GLP-1 and PACAP receptors in human tissues","volume":"157","author":"Wei","year":"1996","journal-title":"Acta Physiol Scand"},{"issue":"3","key":"10.1016\/j.siny.2021.101256_bib76","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1124\/jpet.300.3.958","article-title":"A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells","volume":"300","author":"Perry","year":"2002","journal-title":"J Pharmacol Exp Therapeut"},{"issue":"2","key":"10.1016\/j.siny.2021.101256_bib77","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/jnr.21483","article-title":"Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease","volume":"86","author":"Bertilsson","year":"2008","journal-title":"J Neurosci Res"},{"issue":"8","key":"10.1016\/j.siny.2021.101256_bib78","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/jcbfm.2011.51","article-title":"Exendin-4, a glucagon-like peptide-1 receptor agonist, provides neuroprotection in mice transient focal cerebral ischemia","volume":"31","author":"Teramoto","year":"2011","journal-title":"J Cerebr Blood Flow Metabol"},{"issue":"4","key":"10.1016\/j.siny.2021.101256_bib79","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1055\/s-0028-1105911","article-title":"Anti-apoptotic action of exendin-4 in INS-1 beta cells: comparative protein pattern analysis of isolated mitochondria","volume":"41","author":"Tews","year":"2009","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.siny.2021.101256_bib80","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3389\/fncel.2019.00585","article-title":"Treatment with liraglutide exerts neuroprotection after hypoxic-ischemic brain injury in neonatal rats via the PI3K\/AKT\/GSK3\u03b2 pathway","volume":"13","author":"Zeng","year":"2019","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"10.1016\/j.siny.2021.101256_bib81","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1080\/02699052.2019.1587000","article-title":"GLP-1's role in neuroprotection: a systematic review","volume":"33","author":"Erbil","year":"2019","journal-title":"Brain Inj"},{"issue":"6","key":"10.1016\/j.siny.2021.101256_bib82","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1177\/0271678X17746132","article-title":"Magnesium induces preconditioning of the neonatal brain via profound mitochondrial protection","volume":"39","author":"Koning","year":"2019","journal-title":"J Cerebr Blood Flow Metabol"},{"issue":"6","key":"10.1016\/j.siny.2021.101256_bib83","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41390-019-0511-8","article-title":"Short-term effects of early initiation of magnesium infusion combined with cooling after hypoxia-ischemia in term piglets","volume":"86","author":"Lingam","year":"2019","journal-title":"Pediatr Res"},{"issue":"3","key":"10.1016\/j.siny.2021.101256_bib84","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4103\/2249-4847.159863","article-title":"Multicenter randomized controlled trial of therapeutic hypothermia plus magnesium sulfate versus therapeutic hypothermia plus placebo in the management of term and near-term infants with hypoxic ischemic encephalopathy (The Mag Cool study): a pilot study","volume":"4","author":"Rahman","year":"2015","journal-title":"Journal of Clinical Neonatology"},{"issue":"9","key":"10.1016\/j.siny.2021.101256_bib85","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/jp.2013.65","article-title":"Magnesium for newborns with hypoxic-ischemic encephalopathy: a systematic review and meta-analysis","volume":"33","author":"Tagin","year":"2013","journal-title":"J Perinatol"},{"key":"10.1016\/j.siny.2021.101256_bib86","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3389\/fneur.2020.00449","article-title":"A systematic review of magnesium sulfate for perinatal neuroprotection: what have we learnt from the past decade?","volume":"11","author":"Galinsky","year":"2020","journal-title":"Front Neurol"},{"issue":"2","key":"10.1016\/j.siny.2021.101256_bib87","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1600-079X.2008.00647.x","article-title":"Melatonin protects the mitochondria from oxidative damage reducing oxygen consumption, membrane potential, and superoxide anion production","volume":"46","author":"Lopez","year":"2009","journal-title":"J Pineal Res"},{"issue":"1","key":"10.1016\/j.siny.2021.101256_bib88","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ana.10072","article-title":"Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge","volume":"51","author":"Husson","year":"2002","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.siny.2021.101256_bib89","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1096\/fj.03-1031fje","article-title":"Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism responsible for anti-apoptotic effects of melatonin","volume":"18","author":"Andrabi","year":"2004","journal-title":"Faseb J"},{"issue":"Pt 1","key":"10.1016\/j.siny.2021.101256_bib90","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/brain\/aws285","article-title":"Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model","volume":"136","author":"Robertson","year":"2013","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.siny.2021.101256_bib91","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1159\/000491859","article-title":"Melatonin acts in synergy with hypothermia to reduce oxygen-glucose deprivation-induced cell death in rat Hippocampus organotypic slice cultures","volume":"114","author":"Carloni","year":"2018","journal-title":"Neonatology"},{"key":"10.1016\/j.siny.2021.101256_bib92","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.nbd.2018.10.004","article-title":"Melatonin as an adjunct to therapeutic hypothermia in a piglet model of neonatal encephalopathy: a translational study","volume":"121","author":"Robertson","year":"2019","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10.1016\/j.siny.2021.101256_bib93","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1038\/s41598-020-60858-x","article-title":"High-dose melatonin and ethanol excipient combined with therapeutic hypothermia in a newborn piglet asphyxia model","volume":"10","author":"Robertson","year":"2020","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.siny.2021.101256_bib94","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/jp.2014.186","article-title":"Melatonin use for neuroprotection in perinatal asphyxia: a randomized controlled pilot study","volume":"35","author":"Aly","year":"2015","journal-title":"J Perinatol"},{"issue":"4","key":"10.1016\/j.siny.2021.101256_bib95","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/sj.jcbfm.9600603","article-title":"Endogenous melatonin increases in cerebrospinal fluid of patients after severe traumatic brain injury and correlates with oxidative stress and metabolic disarray","volume":"28","author":"Seifman","year":"2008","journal-title":"J Cerebr Blood Flow Metabol"},{"key":"10.1016\/j.siny.2021.101256_bib96","series-title":"Melatonin for neuroprotection in neonatal encephalopathy: a systematic review & meta-analysis of clinical trials","first-page":"38","author":"Ahmed","year":"2021"},{"issue":"11","key":"10.1016\/j.siny.2021.101256_bib97","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00101-015-0079-6","article-title":"[Neuroprotection by noble gases: new developments and insights]","volume":"64","author":"Fahlenkamp","year":"2015","journal-title":"Anaesthesist"},{"issue":"396","key":"10.1016\/j.siny.2021.101256_bib98","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/24525","article-title":"How does xenon produce anaesthesia?","volume":"26","author":"Franks","year":"1998","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.siny.2021.101256_bib99","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/bja\/89.5.739","article-title":"Neuroprotective and neurotoxic properties of the 'inert' gas, xenon","volume":"89","author":"Ma","year":"2002","journal-title":"Br J Anaesth"},{"issue":"12","key":"10.1016\/j.siny.2021.101256_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115984","article-title":"Argon inhalation attenuates retinal apoptosis after ischemia\/reperfusion injury in a time- and dose-dependent manner in rats","volume":"9","author":"Ulbrich","year":"2014","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.siny.2021.101256_bib101","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1161\/STROKEAHA.107.499822","article-title":"Xenon and hypothermia combine additively, offering long-term functional and histopathologic neuroprotection after neonatal hypoxia\/ischemia","volume":"39","author":"Hobbs","year":"2008","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.siny.2021.101256_bib102","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/ana.20547","article-title":"Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia","volume":"58","author":"Ma","year":"2005","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.siny.2021.101256_bib103","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1161\/01.STR.0000198867.31134.ac","article-title":"Xenon provides short-term neuroprotection in neonatal rats when administered after hypoxia-ischemia","volume":"37","author":"Dingley","year":"2006","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.siny.2021.101256_bib104","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ana.22387","article-title":"Xenon augmented hypothermia reduces early lactate\/NAA and cell death in Perinatal Asphyxia","volume":"70","author":"Faulkner","year":"2011","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.siny.2021.101256_bib105","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/ana.22016","article-title":"Xenon enhances hypothermic neuroprotection in asphyxiated newborn pigs","volume":"68","author":"Chakkarapani","year":"2010","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.siny.2021.101256_bib106","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/jcbfm.2008.163","article-title":"Cooling combined with immediate or delayed xenon inhalation provides equivalent long-term neuroprotection after neonatal hypoxia-ischemia","volume":"29","author":"Thoresen","year":"2009","journal-title":"J Cerebr Blood Flow Metabol"},{"issue":"18","key":"10.1016\/j.siny.2021.101256_bib107","doi-asserted-by":"crossref","first-page":"25640","DOI":"10.18632\/oncotarget.8241","article-title":"Argon protects against hypoxic-ischemic brain injury in neonatal rats through activation of nuclear factor (erythroid-derived 2)-like 2","volume":"7","author":"Zhao","year":"2016","journal-title":"Oncotarget"},{"issue":"29\u201338","key":"10.1016\/j.siny.2021.101256_bib108","article-title":"Inhaled 45-50% argon augments hypothermic brain protection in a piglet model of perinatal asphyxia","volume":"87","author":"Broad","year":"2015","journal-title":"Neurobiol Dis"},{"issue":"15","key":"10.1016\/j.siny.2021.101256_bib109","article-title":"Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe): a proof-of-concept, open-label, randomised controlled trial","volume":"S1474\u20134422","author":"Azzopardi","year":"2015","journal-title":"Lancet Neurol pii"},{"key":"10.1016\/j.siny.2021.101256_bib110","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ebiom.2019.08.034","article-title":"Prospective qualification of early cerebral biomarkers in a randomised trial of treatment with xenon combined with moderate hypothermia after birth asphyxia","volume":"47","author":"Azzopardi","year":"2019","journal-title":"EBioMedicine"},{"issue":"8","key":"10.1016\/j.siny.2021.101256_bib111","first-page":"CD012753","article-title":"Xenon as an adjuvant to therapeutic hypothermia in near-term and term newborns with hypoxic-ischaemic encephalopathy","volume":"8","author":"R\u00fcegger","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.siny.2021.101256_bib112","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/978-3-540-74805-2_16","article-title":"NO\/cGMP-dependent modulation of synaptic transmission","volume":"184","author":"Feil","year":"2008","journal-title":"Handb Exp Pharmacol"},{"issue":"12","key":"10.1016\/j.siny.2021.101256_bib113","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1021\/acschemneuro.0c00244","article-title":"Therapeutic potential of phosphodiesterase inhibitors against neurodegeneration: the perspective of the medicinal chemist","volume":"11","author":"Ribaudo","year":"2020","journal-title":"ACS Chem Neurosci"},{"issue":"3","key":"10.1016\/j.siny.2021.101256_bib114","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1161\/STROKEAHA.113.003606","article-title":"Sildenafil mediates blood-flow redistribution and neuroprotection after neonatal hypoxia-ischemia","volume":"45","author":"Charriaut-Marlangue","year":"2014","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.siny.2021.101256_bib115","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000448327","article-title":"Sildenafil improves brain injury recovery following term neonatal hypoxia-ischemia in male rat pups","volume":"38","author":"Yazdani","year":"2016","journal-title":"Dev Neurosci"},{"issue":"6","key":"10.1016\/j.siny.2021.101256_bib116","doi-asserted-by":"crossref","first-page":"F541","DOI":"10.1136\/archdischild-2014-306284","article-title":"New horizons for newborn brain protection: enhancing endogenous neuroprotection","volume":"100","author":"Hassell","year":"2015","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"11","key":"10.1016\/j.siny.2021.101256_bib117","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.drudis.2015.09.001","article-title":"Neuroprotective agents for neonatal hypoxic-ischemic brain injury","volume":"20","author":"Wu","year":"2015","journal-title":"Drug Discov Today"},{"issue":"3","key":"10.1016\/j.siny.2021.101256_bib118","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.clp.2015.04.004","article-title":"Erythropoietin and neonatal neuroprotection","volume":"42","author":"Juul","year":"2015","journal-title":"Clin Perinatol"},{"issue":"4","key":"10.1016\/j.siny.2021.101256_bib119","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/WNR.0000000000001194","article-title":"Effect of erythropoietin on Fas\/FasL expression in brain tissues of neonatal rats with hypoxic-ischemic brain damage","volume":"30","author":"Huang","year":"2019","journal-title":"Neuroreport"},{"issue":"1","key":"10.1016\/j.siny.2021.101256_bib120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.33549\/physiolres.930749","article-title":"Erythropoietin decreases cytotoxicity and nitric oxide formation induced by inflammatory stimuli in rat oligodendrocytes","volume":"55","author":"Genc","year":"2006","journal-title":"Physiol Res"},{"issue":"5","key":"10.1016\/j.siny.2021.101256_bib121","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1159\/000232558","article-title":"Erythropoietin sustains cognitive function and brain volume after neonatal stroke","volume":"31","author":"Gonzalez","year":"2009","journal-title":"Dev Neurosci"},{"issue":"4","key":"10.1016\/j.siny.2021.101256_bib122","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1203\/pdr.0b013e3180332cec","article-title":"A comparison of high-dose recombinant erythropoietin treatment regimens in brain-injured neonatal rats","volume":"61","author":"Kellert","year":"2007","journal-title":"Pediatr Res"},{"issue":"5","key":"10.1016\/j.siny.2021.101256_bib123","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1113\/JP279131","article-title":"Non-additive effects of adjunct erythropoietin therapy with therapeutic hypothermia after global cerebral ischaemia in near-term fetal sheep","volume":"598","author":"Wassink","year":"2020","journal-title":"J Physiol"},{"issue":"4","key":"10.1016\/j.siny.2021.101256_bib124","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1515\/jpm-2018-0360","article-title":"Erythropoietin in perinatal hypoxic-ischemic encephalopathy: a systematic review and meta-analysis","volume":"47","author":"Razak","year":"2019","journal-title":"J Perinat Med"},{"issue":"5","key":"10.1016\/j.siny.2021.101256_bib125","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/s41390-019-0493-6","article-title":"Placental pathology and neonatal brain MRI in a randomized trial of erythropoietin for hypoxic-ischemic encephalopathy","volume":"87","author":"Wu","year":"2020","journal-title":"Pediatr Res"},{"issue":"4","key":"10.1016\/j.siny.2021.101256_bib126","first-page":"331","article-title":"High-dose erythropoietin for asphyxia and encephalopathy (HEAL): a randomized controlled trial - background","volume":"113","author":"Juul","year":"2018","journal-title":"Aims, and Study Protocol, Neonatology"},{"issue":"5","key":"10.1016\/j.siny.2021.101256_bib127","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/sctm.17-0075","article-title":"A history of cord blood banking and transplantation","volume":"6","author":"Kurtzberg","year":"2017","journal-title":"Stem Cells Transl Med"},{"issue":"2","key":"10.1016\/j.siny.2021.101256_bib128","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1203\/01.pdr.0000197309.08852.f5","article-title":"Spastic paresis after perinatal brain damage in rats is reduced by human cord blood mononuclear cells","volume":"59","author":"Meier","year":"2006","journal-title":"Pediatr Res"},{"issue":"4\u20135","key":"10.1016\/j.siny.2021.101256_bib129","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000374107","article-title":"Human umbilical cord blood cells ameliorate motor deficits in rabbits in a cerebral palsy model","volume":"37","author":"Drobyshevsky","year":"2015","journal-title":"Dev Neurosci"},{"issue":"5","key":"10.1016\/j.siny.2021.101256_bib130","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1113\/JP271104","article-title":"Cord blood mononuclear cells prevent neuronal apoptosis in response to perinatal asphyxia in the newborn lamb","volume":"594","author":"Aridas","year":"2016","journal-title":"J Physiol"},{"issue":"1\u20132","key":"10.1016\/j.siny.2021.101256_bib131","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/pr.2017.260","article-title":"Future perspectives of cell therapy for neonatal hypoxic-ischemic encephalopathy","volume":"83","author":"Nabetani","year":"2018","journal-title":"Pediatr Res"},{"issue":"11","key":"10.1016\/j.siny.2021.101256_bib132","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ni.3002","article-title":"Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications","volume":"15","author":"Wang","year":"2014","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.siny.2021.101256_bib133","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.bbi.2009.10.017","article-title":"Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration","volume":"24","author":"van Velthoven","year":"2010","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.siny.2021.101256_bib134","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.neuroscience.2014.01.018","article-title":"Effects of intravenous administration of umbilical cord blood CD34(+) cells in a mouse model of neonatal stroke","volume":"263","author":"Tsuji","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.siny.2021.101256_bib135","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.neuroscience.2012.03.009","article-title":"The dose-response effect of acute intravenous transplantation of human umbilical cord blood cells on brain damage and spatial memory deficits in neonatal hypoxia-ischemia","volume":"210","author":"de Paula","year":"2012","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.siny.2021.101256_bib136","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1089\/scd.2012.0183","article-title":"Use of human umbilical cord blood mononuclear cells to prevent perinatal brain injury: a preclinical study","volume":"22","author":"Dalous","year":"2013","journal-title":"Stem Cell Dev"},{"issue":"3","key":"10.1016\/j.siny.2021.101256_bib137","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120893","article-title":"Hypothermia augments neuroprotective activity of mesenchymal stem cells for neonatal hypoxic-ischemic encephalopathy","volume":"10","author":"Park","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.siny.2021.101256_bib138","series-title":"Interaction between hypothermia and delayed mesenchymal stem cell therapy in neonatal hypoxic-ischemic brain injury","first-page":"118","author":"Herz","year":"2018"},{"issue":"1","key":"10.1016\/j.siny.2021.101256_bib139","doi-asserted-by":"crossref","first-page":"7665","DOI":"10.1038\/s41598-018-25902-x","article-title":"Hypothermia broadens the therapeutic time window of mesenchymal stem cell transplantation for severe neonatal hypoxic ischemic encephalopathy","volume":"8","author":"Ahn","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.siny.2021.101256_bib140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051253","article-title":"Intranasal mesenchymal stem cell treatment for neonatal brain damage: long-term cognitive and sensorimotor improvement","volume":"8","author":"Donega","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.siny.2021.101256_bib141","series-title":"Intranasally administered mesenchymal stem cells promote a regenerative niche for repair of neonatal ischemic brain injury","first-page":"53","author":"Donega","year":"2014"},{"issue":"5","key":"10.1016\/j.siny.2021.101256_bib142","first-page":"419","article-title":"Nasal administration of stem cells: a promising novel route to treat neonatal ischemic brain damage","volume":"68","author":"van Velthoven","year":"2010","journal-title":"Pediatr Res"},{"issue":"5","key":"10.1016\/j.siny.2021.101256_bib143","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/pr.2015.145","article-title":"Assessment of long-term safety and efficacy of intranasal mesenchymal stem cell treatment for neonatal brain injury in the mouse","volume":"78","author":"Donega","year":"2015","journal-title":"Pediatr Res"},{"key":"10.1016\/j.siny.2021.101256_bib144","series-title":"Human umbilical cord mesenchymal stromal cells as an adjunct therapy with therapeutic hypothermia in a piglet model of perinatal asphyxia","author":"Robertson","year":"2020"},{"issue":"5","key":"10.1016\/j.siny.2021.101256_bib145","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jpeds.2013.11.036","article-title":"Feasibility of autologous cord blood cells for infants with hypoxic-ischemic encephalopathy","volume":"164","author":"Cotten","year":"2014","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.siny.2021.101256_bib146","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1038\/s41598-020-61311-9","article-title":"Autologous cord blood cell therapy for neonatal hypoxic-ischaemic encephalopathy: a pilot study for feasibility and safety","volume":"10","author":"Tsuji","year":"2020","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.siny.2021.101256_bib147","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/sctm.17-0102","article-title":"Effect of autologous cord blood infusion on motor function and brain connectivity in young children with cerebral palsy: a randomized, placebo-controlled trial","volume":"6","author":"Sun","year":"2017","journal-title":"Stem Cells Transl Med"},{"issue":"5","key":"10.1016\/j.siny.2021.101256_bib148","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.jpeds.2013.12.011","article-title":"Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial","volume":"164","author":"Chang","year":"2014","journal-title":"J Pediatr"},{"issue":"12","key":"10.1016\/j.siny.2021.101256_bib149","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/sctm.17-0219","article-title":"Mesenchymal stem cells for severe intraventricular hemorrhage in preterm infants: phase I dose-escalation clinical trial","volume":"7","author":"Ahn","year":"2018","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"10.1016\/j.siny.2021.101256_bib150","article-title":"Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition","volume":"1","author":"Fisher","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.siny.2021.101256_bib151","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/STROKEAHA.119.026589","article-title":"Intravenously transplanted human multilineage-differentiating stress-enduring cells afford brain repair in a mouse lacunar stroke model","volume":"51","author":"Abe","year":"2020","journal-title":"Stroke"},{"key":"10.1016\/j.siny.2021.101256_bib152","article-title":"Melatonin and\/or erythropoietin combined with hypothermia in a piglet model of perinatal asphyxia","author":"Pang","year":"2020","journal-title":"Brain Commun"},{"issue":"1","key":"10.1016\/j.siny.2021.101256_bib153","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12887-018-1389-z","article-title":"Combination therapy with erythropoietin, magnesium sulfate and hypothermia for hypoxic-ischemic encephalopathy: an open-label pilot study to assess the safety and feasibility","volume":"19","author":"Nonomura","year":"2019","journal-title":"BMC Pediatr"},{"issue":"5","key":"10.1016\/j.siny.2021.101256_bib154","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/jcbfm.2014.259","article-title":"How long is too long for cerebral cooling after ischemia in fetal sheep?","volume":"35","author":"Davidson","year":"2015","journal-title":"J Cerebr Blood Flow Metabol"},{"key":"10.1016\/j.siny.2021.101256_bib155","doi-asserted-by":"crossref","first-page":"25178","DOI":"10.1038\/srep25178","article-title":"Extending the duration of hypothermia does not further improve white matter protection after ischemia in term-equivalent fetal sheep","volume":"6","author":"Davidson","year":"2016","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.siny.2021.101256_bib156","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/apa.14800","article-title":"Why results from Bayesian statistical analyses of clinical trials with a strong prior and small sample sizes may be misleading the case of the NICHD Neonatal Research Network Late Hypothermia Trial","volume":"108","author":"Wall\u00f8e","year":"2019","journal-title":"Acta Paediatr"}],"container-title":["Seminars in Fetal and Neonatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744165X21000640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744165X21000640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:46:25Z","timestamp":1761677185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1744165X21000640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":156,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1744165X21000640"],"URL":"https:\/\/doi.org\/10.1016\/j.siny.2021.101256","relation":{},"ISSN":["1744-165X"],"issn-type":[{"value":"1744-165X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapies for neonatal encephalopathy: Targeting the latent, secondary and tertiary phases of evolving brain injury","name":"articletitle","label":"Article Title"},{"value":"Seminars in Fetal and Neonatal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.siny.2021.101256","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101256"}}